Selegiline
Selegiline is a brain enzyme inhibitor used alongside levodopa/carbidopa to help people with Parkinson's disease get more consistent, longer-lasting relief from their symptoms.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 14 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Selegiline: Patient Information Guide
A plain-language walkthrough of Selegiline — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Selegiline is approved as an add-on treatment for Parkinson's disease in people whose response to levodopa/carbidopa is declining. It is not used on its own. Specific benefits shown in studies include:
- Reducing the total daily amount of levodopa/carbidopa needed
- Cutting down "off" time — periods when Parkinson's symptoms break through between doses
- Reducing end-of-dose akinesia (stiffness and slowness as medication wears off)
- Decreasing tremor and drooling (sialorrhea)
- Improving speech and ability to dress independently
- Improving overall mobility and disability rating
⚙️How it works▾
Selegiline works by blocking an enzyme called MAO-B (monoamine oxidase type B), which normally breaks down dopamine in the brain. In Parkinson's disease, dopamine-producing cells are lost, so protecting what dopamine remains is a key strategy. By irreversibly locking onto MAO-B, selegiline slows the breakdown of dopamine, allowing it to remain active in the brain longer. There may also be additional ways it boosts dopamine activity that researchers are still studying.
At the recommended dose, selegiline targets MAO-B selectively — which matters because the other form, MAO-A, helps protect the gut and liver from blood pressure-raising substances in food. Exceeding the recommended dose erodes this selectivity and raises the risk of dangerous reactions.
💊How it's taken▾
Selegiline is taken once a day in the morning, before breakfast. The orally dissolving tablet form is placed on top of the tongue — it dissolves in seconds without water. Avoid eating or drinking for 5 minutes before and after each dose, since food can significantly reduce how much medication is absorbed.
- Treatment is typically started at a lower dose for at least 6 weeks before any increase is considered
- There is no evidence that going above the maximum recommended dose helps — and it significantly increases risk
- For mild-to-moderate liver disease, a lower dose is used; the drug is not recommended in severe liver or kidney disease
Always follow your prescriber's exact instructions and do not adjust your dose on your own.
🤒Side effects — in detail▾
Like most Parkinson's medications, selegiline can cause a range of side effects — some mild, some that need prompt attention:
- Nausea
- Dizziness, lightheadedness, or fainting
- Stomach pain
- Dry mouth
- Vivid dreams
- Headache
- Confusion or hallucinations
- Uncontrolled movements (dyskinesia)
Call your doctor right away if you experience hallucinations, sudden fainting, compulsive behaviors that feel out of character, or any signs of serotonin syndrome — such as agitation, fever, rapid heart rate, or muscle rigidity. These can be serious and need fast attention.
⚠️Warnings & precautions▾
- Tyramine and blood pressure: At doses higher than recommended, selegiline can cause dangerous blood pressure spikes after eating tyramine-rich foods (aged cheeses, cured meats, red wine). Even at the recommended dose, rare reactions have been reported. Never exceed the prescribed dose.
- Serotonin syndrome: Combining selegiline with antidepressants (SSRIs, tricyclics) or opioids can trigger a life-threatening condition involving fever, agitation, muscle rigidity, and rapid heart rate. A 14-day washout period is required between stopping selegiline and starting these drugs.
- Falling asleep suddenly: Selegiline may cause people to fall asleep without warning during everyday activities — including driving. Use caution until you know how it affects you.
- Impulse control: Some people develop compulsive behaviors — gambling, spending, eating, or sexual urges — that feel difficult to control. Report any unusual behavioral changes to your doctor.
- Don't stop abruptly: Stopping selegiline suddenly can cause high fever and confusion. Talk to your doctor before making any changes.
- Phenylketonuria (PKU): The dissolving tablet contains phenylalanine — people with PKU must inform their doctor.
🔀What it interacts with▾
Selegiline has several serious — sometimes life-threatening — drug and food interactions. Make sure your entire care team knows everything you take:
- Opioid painkillers (meperidine, tramadol, methadone) — can cause a fatal reaction; absolutely contraindicated, with a required 14-day gap after stopping selegiline
- Other MAO inhibitors (including the antibiotic linezolid) — risk of hypertensive crisis; contraindicated, 14-day gap required
- SSRIs and tricyclic antidepressants (fluoxetine, sertraline, paroxetine, amitriptyline, protriptyline) — risk of serious or fatal serotonin syndrome
- Dextromethorphan (in many OTC cough syrups) — can cause psychosis or bizarre behavior; contraindicated
- St. John's Wort (herbal supplement) — contraindicated due to serious interaction risk
- Cyclobenzaprine (muscle relaxant) — contraindicated
- Sympathomimetics like ephedrine (in some decongestants) — can cause uncontrolled high blood pressure
- Tyramine-rich foods (aged cheese, cured meats, fermented foods, red wine, some OTC cold medicines) — can raise blood pressure dangerously, especially above recommended doses
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor about all medications, supplements, and herbal products you take — the interaction list for selegiline is long and some are life-threatening
- Liver disease: Dose reduction needed for mild-to-moderate liver impairment; not recommended for severe liver disease
- Kidney disease: Not recommended for severe kidney impairment or end-stage renal disease (dialysis)
- Pregnancy: Animal studies suggest possible fetal harm — discuss the risks and benefits carefully with your doctor
- Phenylketonuria (PKU): The orally dissolving tablet contains phenylalanine; inform your doctor if you have this condition
- History of psychosis or hallucinations: Selegiline may worsen these symptoms
- Low blood pressure: Selegiline can further lower blood pressure, especially when standing up
🚑If you take too much▾
There is limited real-world data on selegiline overdose, but at high doses the drug loses its MAO-B selectivity and can affect MAO-A as well, leading to a picture similar to overdose with non-selective MAO inhibitors. Symptoms may be delayed up to 12 hours and could include severe headache, agitation, hallucinations, seizures, very high or very low blood pressure, rapid or irregular heartbeat, and loss of consciousness.
If an overdose is suspected, go to the nearest emergency room immediately — the label strongly recommends at least 48 hours of continuous monitoring in a hospital setting.
📡Pharmacodynamics — effects in the body▾
At the recommended dose, selegiline selectively blocks the MAO-B enzyme, slowing the breakdown of dopamine in the brain. Studies examining higher doses showed that blood pressure sensitivity to tyramine (a substance found in certain foods) starts to increase once the dose exceeds the recommended level, because MAO-A — which protects against tyramine absorption — begins to be inhibited as well. This is why staying within the prescribed dose range is so important: going above it shifts the drug from a targeted brain therapy to a broader enzyme blocker with more unpredictable effects on blood pressure.
🔬Pharmacokinetics — how your body processes it▾
When taken as an orally dissolving tablet placed on the tongue, selegiline is absorbed very rapidly — detectable in the bloodstream within 5 minutes, with peak levels reached in about 10–15 minutes. Because it's absorbed through the mouth's lining before reaching the stomach, it bypasses first-pass liver processing, leading to higher drug levels compared to a standard swallowed tablet. Food significantly reduces absorption, which is why you should avoid eating or drinking for 5 minutes before and after each dose.
Up to 85% of selegiline binds to proteins in the blood. It is metabolized in the liver (primarily by enzymes CYP2B6 and CYP3A4) into several breakdown products, including small amounts of l-methamphetamine and l-amphetamine metabolites. Steady-state blood levels are reached after about 8 days of daily use, and the effective half-life at steady state is around 10 hours.
📦How to store it▾
stored inside a clear child-resistant outer pouch and is packaged in a carton. Store at controlled room temperature, 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store blister tablets in sachet pouch at all times.
📄 Written from Selegiline’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Selegiline
102 supplements and herbal products have documented interactions with Selegiline in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 14
- Moderate · 75
- Minor · 13
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Selegiline has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Selegiline — the kind of thing our pharmacy team would talk through with you at the counter.
Why am I taking selegiline if I'm already on levodopa? Isn't one medication enough? ▾
How do I take the dissolving tablet? It seems different from regular pills. ▾
Are there foods I need to avoid while taking selegiline? ▾
What medications can't I take with selegiline? I use a cough syrup sometimes. ▾
I've been feeling a little drowsy — is it safe for me to drive? ▾
Can I just stop taking selegiline if I decide I don't want it anymore? ▾
Is Selegiline available over the counter? ▾
When was Selegiline first available? ▾
Who makes Selegiline? ▾
💬 Answers drafted from Selegiline’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Selegiline comes
Selegiline is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
Capsule
Skin patch
Orally disintegrating tablet
📊 Selegiline across the U.S. market
How Selegiline appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (12) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Selegiline is used
A general measure of how commonly Selegiline is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Selegiline is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Selegiline prescribed? Of the 1,596 medications we measure, Selegiline ranks #1,174 by Medicaid prescriptions — more than 26% of them.
Utilization by Selegiline product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
selegiline hydrochloride 5 MG Oral Tablet Most dispensed
Summed across the 2 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 859193
24 HR selegiline 0.25 MG/HR Transdermal System
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 865206
selegiline hydrochloride 5 MG Oral Capsule
Summed across the 3 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 859186
24 HR selegiline 0.5 MG/HR Transdermal System
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 865214
24 HR selegiline 0.375 MG/HR Transdermal System
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 865210
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Selegiline, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 8 of 40 listed Selegiline NDCs with Medicaid activity.
🔍 Compare Selegiline products
A representative set of FDA-listed product records for Selegiline — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 5 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Marlex Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Novitium Pharma LLC | ANDA | View NDC → |
| 5 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 5 mg | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 💊Orally disintegrating tablet | ||||
| 1.25 mg | Oral | Bausch Health US, LLC × 2 listings | NDA | View NDC → |
| 1.25 mg | — | Catalent U.k. Swindon Zydis Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Skin patch | ||||
| 6 mg/24h | Transdermal | Mylan Specialty L.P. | NDA | View NDC → |
| 9 mg/24h | Transdermal | Mylan Specialty L.P. | NDA | View NDC → |
| 12 mg/24h | Transdermal | Mylan Specialty L.P. | NDA | View NDC → |
| SELEGILINE 6 mg/24h | Transdermal | Viatris Specialty LLC | NDA | View NDC → |
| SELEGILINE 9 mg/24h | Transdermal | Viatris Specialty LLC | NDA | View NDC → |
| SELEGILINE 12 mg/24h | Transdermal | Viatris Specialty LLC | NDA | View NDC → |
| 💊Tablet | ||||
| 5 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | A2A Integrated Pharmaceuticals | ANDA | View NDC → |
| 5 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 5 mg | Oral | Golden State Medical Supply, Inc. × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | i3 Pharmaceuticals, LLC × 3 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Apicore Pharmaceuticals private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Czech-Gen, a,s | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dipharma Francis Srl × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Embio Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | EUROAPI Hungary Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Farmak, a,s | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Matrix Pharmacorp Private Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
Showing 46 of 46 products — FDA National Drug Code Directory. See every product, package size and price: browse all 46 Selegiline NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Selegiline — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Selegiline in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Selegiline went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 9639 5 dose forms · 11 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 643052In current FDA listingsClinical drug / strength (SCD) hydrochloride 1.25 MGRxCUI 859190 -
Dose form (SCDF) Oral Capsule RxCUI 374522In current FDA listingsClinical drug / strength (SCD) hydrochloride 5 MGRxCUI 859186 -
Dose form (SCDF) Oral Solution RxCUI 373841No current FDA listingClinical drug / strength (SCD) hydrochloride 2 MG/MLRxCUI 865222 -
Dose form (SCDF) Oral Tablet RxCUI 373842In current FDA listingsClinical drug / strength (SCD) hydrochloride 1.25 MGRxCUI 865218hydrochloride 10 MGRxCUI 865220hydrochloride 15 MGRxCUI 880383hydrochloride 30 MGRxCUI 897069hydrochloride 5 MGRxCUI 859193 -
Dose form (SCDF) Transdermal System RxCUI 1806068In current FDA listingsClinical drug / strength (SCD) 24 HR selegiline 0.25 MG/HRRxCUI 86520624 HR selegiline 0.375 MG/HRRxCUI 86521024 HR selegiline 0.5 MG/HRRxCUI 865214
Look up RxCUI 9639 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Selegiline is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 1 more on the FDA NDC directory.
RxNorm drug class
Selegiline belongs to the Monoamine Oxidase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 14 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Bausch Health US, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.